Last reviewed · How we verify
Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection
Approved treatments
- Ppsv23 · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection treatment landscape brief
- Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection treatment updates RSS
Frequently asked questions about Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection
What drugs treat Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection?
Tracked treatments include Ppsv23.
What is the treatment for Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection?
Standard treatment for Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection includes Ppsv23. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection patent cliff · Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with HIV infection CI report
- Treatment: Ppsv23 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing